Paul Jenkinson Net Worth & Insider Trades

Paul Jenkinson - Chief Financial Officer, Kite Pharma, Inc

As of October 5, 2017

What is Paul Jenkinson's Net Worth?

The current estimated net worth of Kite Pharma, Inc's Chief Financial Officer, Paul Jenkinson, is estimated to be about $1.36M . Paul Jenkinson owns about 12,462 units of Kite Pharma, Inc common stock. In the last year at Kite Pharma, Inc, Paul Jenkinson has sold an estimated value of $710.32K worth.

What is Paul Jenkinson's Past Insider Trading?

Paul Jenkinson's largest purchase order was 3,450 units , worth over $250.43K on May 10, 2017. Paul Jenkinson's largest sale order was 948 units , worth over $170.32K on September 27, 2017. In total, Paul Jenkinson has made about 5 transactions over a year of their time at Kite Pharma, Inc. Paul Jenkinson usually trades in May, with the busiest year in 2017.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PAUL JENKINSON

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Paul Jenkinson's' Mailing Address?

  • Mailing address is C/o Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404 CA

What are Kite Pharma, Inc's Past Insider Trades?

Kite Pharma, Inc's most recent insider trade came on September 27, 2017 by Shawn Tomasello who sold 4,203 units worth $755.13K . In the last 2 years, insiders at Kite Pharma, Inc have sold an estimated value of $864.82M and bought an estimated value of $20.6M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Cynthia Butitta, Chief Operating Officer,  Jeffrey Wiezorek, SVP Clinical Development,  and David Chang, EVP .

Kite Pharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...